Cannabics Pharmaceuticals Company Insiders
| CNBX Stock | USD 0.01 0 15.00% |
Cannabics Pharmaceuticals employs about 5 people. The company is managed by 10 executives with a total tenure of roughly 12 years, averaging almost 1.0 years of service per executive, having 0.5 employees per reported executive. Break down of Cannabics Pharmaceuticals' management performance can provide insight into the company performance.
| CPA CPA Insider Chief Officer |
| Gabriel Yariv Insider COO Pres |
Cannabics |
Cannabics Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (1.0031) % which means that it has lost $1.0031 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (42.8936) %, meaning that it created substantial loss on money invested by shareholders. Cannabics Pharmaceuticals' management efficiency ratios could be used to measure how well Cannabics Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Cannabics Pharmaceuticals Workforce Comparison
Cannabics Pharmaceuticals is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 738. Cannabics Pharmaceuticals maintains roughly 5.0 in number of employees contributing less than 1% to equities under Health Care industry.
Cannabics Pharmaceuticals Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Cannabics Pharmaceuticals Price Series Summation is a cross summation of Cannabics Pharmaceuticals price series and its benchmark/peer.
Cannabics Pharmaceuticals Notable Stakeholders
A Cannabics Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cannabics Pharmaceuticals often face trade-offs trying to please all of them. Cannabics Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cannabics Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Eyal Barad | COO, Director | Profile | |
| CPA CPA | Chief Officer | Profile | |
| Gabriel Yariv | COO Pres | Profile | |
| Tal Mofkadi | Financial Board | Profile | |
| Sanja Goldberg | Chief Officer | Profile | |
| Sigalit ArielyPortnoy | Validation Regulation | Profile | |
| Ilya MD | Head Devel | Profile | |
| Yasha Borstein | Chief Data Officer | Profile | |
| Yaakov Waksman | Head Research | Profile | |
| Noam Permont | VP Relations | Profile |
About Cannabics Pharmaceuticals Management Performance
The success or failure of an entity such as Cannabics Pharmaceuticals often depends on how effective the management is. Cannabics Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cannabics management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cannabics management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
CNBX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of cannabinoid-based treatments and therapies for cancer. CNBX Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland. Cnbx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 10 people.
Please note, the imprecision that can be found in Cannabics Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cannabics Pharmaceuticals. Check Cannabics Pharmaceuticals' Beneish M Score to see the likelihood of Cannabics Pharmaceuticals' management manipulating its earnings.
Cannabics Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Cannabics Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cannabics Pharmaceuticals within its industry.Cannabics Pharmaceuticals Manpower Efficiency
Return on Cannabics Pharmaceuticals Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 744.6K | |
| Net Loss Per Executive | 372.3K |
Additional Tools for Cannabics Pink Sheet Analysis
When running Cannabics Pharmaceuticals' price analysis, check to measure Cannabics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannabics Pharmaceuticals is operating at the current time. Most of Cannabics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cannabics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannabics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cannabics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.